Related Experiment Video
Updated: Mar 10, 2026

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
Published on: November 7, 2025
Management of Node-Positive and Oligometastatic Prostate Cancer
James R Broughman1, Ronald C Chen2
1Department of Radiation Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC; School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC.
Abstract:
Historically, stage IV prostate cancer was considered incurable. Although node-positive and oligometastatic prostate cancers are both classified as stage IV, these likely represent distinct clinical groups, and some patients may be curable with aggressive multimodality treatments. There is a lack of randomized evidence, but retrospective studies suggest that radical prostatectomy or radiotherapy may improve survival in these patients. This is an area of great current research interest and prospective randomized trials are needed to help define the optimal treatments for these patients.

